HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Israel
273254
Filed on 2020-03-12
273254
Filed on 2020-03-12
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
European Patent
18792591.2
Filed on 2018-09-19
18792591.2
Filed on 2018-09-19
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Eurasian Patent
202090652
Filed on 2020-04-02
202090652
Filed on 2020-04-02
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Costa Rica
2020-0150
Filed on 2018-09-19
2020-0150
Filed on 2018-09-19
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
China
201880060535.4
Filed on 2018-09-19
201880060535.4
Filed on 2018-09-19
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Canada
3076339
Filed on 2018-09-19
3076339
Filed on 2018-09-19
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Brazil
BR112020005469-0
Filed on 2018-09-19
BR112020005469-0
Filed on 2018-09-19
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Australia
2018335274
Filed on 2018-09-19
2018335274
Filed on 2018-09-19
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Japan
2020-001954
Filed on 2020-01-09
2020-001954
Filed on 2020-01-09
T CELL RECEPTORS RECOGNIZING MUTATED P53
US Patent 11,939,365
Filed on 2020-03-26
Filed on 2020-03-26